IndraLab
Statements
reach
"As shown in Fig. 6e, f and Supplementary Fig. 9a, b, HY041004 remarkably suppressed the cell proliferation and colony formation of HT-29-KRAS in vitro, and the effect of HY041004 on HT-29-KRAS is significantly stronger than that on HT-29-KRAS , whereas KRAS covalent inhibitors MRTX-849 only selectively inhibited KRAS CRC cells (Supplementary Fig. 9b), suggesting the potential of JOSD2 inhibition as the promising pan-KRAS-mutation-targeting strategy."